Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Inflammation may help explain how GLP-1 drugs prevent AFib New research presented at Heart Rhythm 2026 suggests taking GLP-1 receptor agonists (GLP-1-RAs) may reduce the risk of atrial fibrillation (AFib) and improve survival through mechanisms that extend beyond weight loss alone
Retatrutide and other investigational compounds are not approved by the U.S
Even a 12-14 hour overnight fasting window may help improve how responsive your body is to the GLP-1 it produces, says Jean-Marc
IBS is a common functional gut disorder, affecting an estimated 1015% of adults (especially women), and is characterized by chronic abdominal pain and changes in bowel habits
